Quest PharmaTech (TSXV:QPT) Total Assets : C$67.34 Mil (As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Total Assets?

Quest PharmaTech's Total Assets for the quarter that ended in Oct. 2023 was C$67.34 Mil.

During the past 12 months, Quest PharmaTech's average Total Assets Growth Rate was -24.10% per year. During the past 3 years, the average Total Assets Growth Rate was 247.60% per year. During the past 5 years, the average Total Assets Growth Rate was 193.10% per year. During the past 10 years, the average Total Assets Growth Rate was 93.80% per year.

During the past 13 years, Quest PharmaTech's highest 3-Year average Total Assets Growth Rate was 564.20%. The lowest was -65.30%. And the median was 4.90%.

Total Assets is connected with ROA %. Quest PharmaTech's annualized ROA % for the quarter that ended in Oct. 2023 was -14.66%. Total Assets is also linked to Revenue through Asset Turnover. Quest PharmaTech's Asset Turnover for the quarter that ended in Oct. 2023 was 0.00.

Quest PharmaTech Total Assets Historical Data

The historical data trend for Quest PharmaTech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Total Assets Chart

Quest PharmaTech Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Total Assets

Get a 7-Day Free Trial

5.81

4.45

175.61

91.03

84.36

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Total Assets	Get a 7-Day Free Trial															89.10	84.36	79.08	69.72	67.34

Quest PharmaTech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Quest PharmaTech's Total Assets for the fiscal year that ended in Jan. 2023 is calculated as

Total Assets	=	Total Equity (A: Jan. 2023 )	+	Total Liabilities (A: Jan. 2023 )
	=	83.252	+	1.106
	=	84.36

Quest PharmaTech's Total Assets for the quarter that ended in Oct. 2023 is calculated as

Total Assets	=	Total Equity (Q: Oct. 2023 )	+	Total Liabilities (Q: Oct. 2023 )
	=	66.172	+	1.165
	=	67.34

Quest PharmaTech (TSXV:QPT) Total Assets Explanation

Total Assets is connected with ROA %.

Quest PharmaTech's annualized ROA % for the quarter that ended in Oct. 2023 is

ROA %	=	Net Income (Q: Oct. 2023 )	/	( (Total Assets (Q: Jul. 2023 )	+	Total Assets (Q: Oct. 2023 ))	/ count )
	=	-10.044	/	( (69.718	+	67.337)	/ 2 )
	=	-10.044	/	68.5275
	=	-14.66 %

Note: The Net Income data used here is four times the quarterly (Oct. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Quest PharmaTech's Asset Turnover for the quarter that ended in Oct. 2023 is

	Asset Turnover
=	Revenue (Q: Oct. 2023 )	/	( (Total Assets (Q: Jul. 2023 )	+	Total Assets (Q: Oct. 2023 ))	/ count )
=	0	/	( (69.718	+	67.337)	/ 2 )
=	0	/	68.5275
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Quest PharmaTech Total Assets Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines